Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ELUT
ELUT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELUT News
Plus Therapeutics Prices Public Offering, Raising $15 Million
Jan 15 2026
NASDAQ.COM
Elutia Showcases NXT-41x Antibiotic-Eluting Biomatrix Technology
Jan 09 2026
Newsfilter
After-Hours Gains on Friday: Biotech and Genomics Stocks Demonstrate Resilience
Dec 22 2025
NASDAQ.COM
Post-Market Winners: A Calm Trading Day Highlighted by a Notable Biotech Rise
Dec 17 2025
NASDAQ.COM
Elutia Welcomes Experienced MedTech Leader Guido J. Neels to Its Board of Directors
Oct 10 2025
Newsfilter
Analysts' Picks: The 3 Most Trending Stocks as of October 1, 2025
Oct 01 2025
TipRanks
Biotech Stocks Surge After Hours Due to Trial Advancements, Funding Developments, and Anticipated Milestones
Sep 17 2025
NASDAQ.COM
Elutia to sell bioenvelopes division to Boston Scientific for $88 million
Sep 11 2025
Yahoo Finance
Lake Street Reiterates Buy Rating on Elutia, Adjusts Price Target to $6
Sep 10 2025
Benzinga
Elutia Sells BioEnvelope Division to Boston Scientific Corporation for $88 Million
Sep 09 2025
Newsfilter
Elutia to Transfer EluPro and CanGaroo Bioenvelopes to Boston Scientific
Sep 09 2025
NASDAQ.COM
Boston Scientific acquires Elutia's bioenvelope division for $88 million
Sep 09 2025
SeekingAlpha
Everything You Should Know About ELUTIA INC (ELUT) Upgrade to Buy Rating
Sep 01 2025
NASDAQ.COM
Elutia Posts Narrower Loss in Fiscal Q2
Aug 14 2025
NASDAQ.COM
Elutia (ELUT) Q2 2025 Earnings Call Transcript
Aug 14 2025
NASDAQ.COM
New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices
Jul 01 2025
Newsfilter
Show More News
